海角社区

McMichael has published numerous articles and book chapters on the subjects of scalp and hair disorders and quality of life issues surrounding disorders of pigmentation. She is listed in Best Doctors in America and is a diplomat of the American Board of Dermatology. McMichael has served on several editorial review boards and is a contributing editor for Cosmetic Dermatology as well as a contributing editor for reviews in The Dermatologist.

Marcus Bosenberg MD, PhD, is a physician scientist who directs a leading melanoma research laboratory, is Co-Leader of the Cancer Immunology Program of Yale Cancer Center, Director of the Yale Center for Immuno-Oncology, Contact PI of the Yale SPORE in Skin Cancer, Director of the Center for Precision Cancer Modeling, and is a practicing dermatopathologist at Yale Dermatopathology through Yale Medicine.
In his research, Dr. Bosenberg studies factors that regulate anti-cancer immune responses. His laboratory has developed several widely utilized mouse models in order to study how melanoma forms and progresses, to test new cancer therapies, and how the immune system can be stimulated to fight cancer. He works to translate basic scientific findings into improvements in cancer diagnosis and therapy. He has published over 200 peer-reviewed articles and is a member of the Yale Cancer Center Executive Committee.
Dr. Bosenberg mentors undergraduate, graduate, medical, and MD-PhD students in his laboratory, teaches at Yale School of Medicine, and trains resident physicians, fellows, and postdoctoral fellows.

Education & Training:
Research Fellow-Dana-Farber Cancer Institute (2002)
Fellow-Harvard Medical School Dermatopathology Training Program (2000)
Chief Resident-Brigham & Women's Hospital (1999)
Resident-Brigham & Women's Hospital (1998)
Research Fellow-University of Wisconsin (1996)
MD-Cornell University Medical College (1994)
PhD-Cornell University Medical College (1993)
BA-Cornell University (1986)

Dr. Kluger is a medical oncologist who sees patients with melanoma and renal cell carcinoma. Her research interests focus on developing new drug regimens and biomarkers predictive of response to therapies in melanoma and renal cell carcinoma. She participates in a number of clinical trials studying new agents for the treatment of these diseases, both targeting the immune system and the cancer cell. She runs an active research laboratory that studies tumor and immune cells from patients treated with novel therapies to determine mechanisms of resistance to therapy and mediators of toxicity from immune checkpoint inhibitors. The laboratory also conducts pre-clinical studies to improve treatment regimens for patients with melanoma, renal cell carcinoma or brain metastasis.
Please visit the lab website at:
https://sites.google.com/yale.edu/hklugerlab/home?authuser=3

Education & Training:
Fellow-Yale University School of Medicine (2002)
Resident-University of New Mexico (1995)
MD-Tel Aviv University (1993)

To Kathleen C. Suozzi, MD, the prevention and reversal of sun damage has become a passion. 鈥淚n my dermatology care and research, I see how sun exposure leads to the development of skin cancers and causes the skin to age prematurely,鈥� she says.
Dr. Suozzi specializes in the treatment of skin cancer with a technique called Mohs surgery. The technique is used to remove cancer cells layer by layer, while preserving normal tissue. She received advanced training in dermatologic surgery at Yale School of Medicine. She is widely published in scientific journals and has presented her research about how skin cancer develops at national conferences including the American Academy of Dermatology, the American Society of Dermatologic Surgery, the Society of Investigative Dermatology and the American College of Mohs Surgery. She鈥檚 committed to alerting people about the dangers of sun exposure. 鈥淧eople accumulate sun damage over a lifetime, starting in childhood. I frequently hear from patients that they were not aware of the risks of sun exposure during their youth,鈥� she says. "But it is never too late to start protecting your skin from UV damage."
In addition to treating skin cancers, Dr. Suozzi uses advanced technologies such as photodynamic therapy, laser treatments and medications to help treat UV-induced damage to the skin. "These technologies can help reverse visible signs of aging and address precancerous changes in the skin,鈥� she says.

Education & Training:
Resident-Yale School of Medicine (2016)
Internship-Memorial Sloan-Kettering Cancer Center (2013)
MD-NYU School Of Medicine (2012)
BS-Duke Univeristy, Biology (2005)

Honors & Recognition:
2022 Rising Star Award-Academic Cosmetic Dermatologists (AACD)

Jonathan Leventhal, MD, is the director of the Onco-Dermatology Program at Smilow Cancer Hospital at Yale New Haven. He treats patients undergoing cancer treatment who experience itchy or painful rashes, as well as hair and nail changes that can result from either their disease or treatment, including chemotherapy, immunotherapy, radiation or stem cell transplantation.
鈥淥ne of the most rewarding aspects of my job is improving the quality of life for patients with cancer who are affected by adverse skin events,鈥� he says.
Seeing an onco-dermatologist like Dr. Leventhal can make the difference between a patient being able to continue receiving a cancer treatment or having to be taken off it when the skin conditions become too severe. 鈥淚f left untreated, some skin, hair and nail conditions can become quite debilitating, even disfiguring and may negatively impact health and ability to perform day-to-day activities,鈥� says Dr. Leventhal. He helps to manage these skin problems so that patients with cancer can continue their treatments and enjoy a better quality of life.
In addition to his role at Smilow, Dr. Leventhal, an associate professor of dermatology and associate director of the residency program at Yale School of Medicine, cares for patients with a wide range of skin conditions in Yale Medicine Dermatology鈥檚 New Haven and Branford locations. He performs routine skin cancer screening examinations and also treats general skin problems鈥攆rom acne to psoriasis to eczema. He is also the Associate Residency Program Director and is Principal Investigator of several clinical trials involving the management of cutaneous reactions to cancer therapy.
"Every day I am excited to come to work, treating various skin conditions affecting my patients and helping patients with cancer continue their potentially life-saving treatments,鈥� says Dr. Leventhal. 鈥淪kin diseases can impact the way people see themselves and can affect how people feel, both physically and emotionally. My work is particularly gratifying when I can improve my patients' overall comfort, happiness and health.鈥�

Education & Training:
Resident- Yale University School of Medicine (2016)
Intern- NYU Langone Hospital - Long Island (2013)
MD- New York University (2012)

Honors & Recognition:
2018 Medical Education Fellowship
2015 Hugh L. Dwyer Memorial Fund Award for Clinical Excellence

Academic Director, Mohs and Dermatologic Surgery CenterDirector, High-Risk Skin Cancer Clinic, Dana-Farber Brigham Cancer Center Director, Micrographic Surgery and Dermatologic Oncology Fellowship Program
Associate Professor of Dermatology, Harvard Medical School







Leadership Title

Academic Director, Mohs and Dermatologic Surgery Center
Director, High-Risk Skin Cancer Clinic, Dana-Farber Brigham Cancer Center
Program Director, Micrographic Surgery and Dermatologic Oncology Fellowship Program


 

Specialties
Dermatology



Clinical Interests

Basal Cell Carcinoma
Cutaneous Oncology (Skin Cancer)
Dermatologic Oncology
Melanoma
Mohs Surgery
Non-Melanoma Skin Cancer
Public Health
Squamous Cell Carcinoma











 
Education





Internship
New York University Langone Medical Center, 2010 - 2011

 

Medical School
New York University School of Medicine, 2006 - 2010

 

Residency
Albert Einstein College of Medicine, 2011 - 2014



Board Certifications
Dermatology, 2014
Micrographic Dermatologic Surgery, 2021

Director, Mohs and Dermatologic Surgery Center Brigham and Women's Faulkner Hospital, Director, Mohs Surgery, VA Boston Healthcare System
Assistant Professor, Harvard Medical School
Dermatology

 







Leadership Title

Director, Mohs and Dermatologic Surgery Center
Director, Mohs Surgery, VA Boston Healthcare System


 

Specialties
Dermatology



Clinical Interests

Basal Cell Carcinoma
Cosmetic Dermatology
Cutaneous Oncology (Skin Cancer)
Laser And Cosmetic Surgery
Melanoma
Mohs Surgery
Non-Melanoma Skin Cancer
Squamous Cell Carcinoma












 
Education

Internship
Memorial Sloan Kettering Cancer Center, 2011 - 2012

 

Medical School
Yale University School of Medicine, 2006 - 2011

 

Residency
Yale New Haven Hospital, 2012 - 2015



Board Certifications
Dermatology, 2015
Micrographic Dermatologic Surgery, 2021



Fellowship
Northwestern University Feinberg School of Medicine, 2015 - 2016